Skip to main content
OpenTrials

Clinical trial condition

Coronary Restenosis

Explore clinical trials studying Coronary Restenosis. Study availability and eligibility vary by location and protocol.

85 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Coronary Restenosis trial results

Completed

Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis

NCT02944890

Conditions
Cardiovascular Diseases, Coronary Disease, Coronary Restenosis, +4 more
Locations
  • Beijing Chaoyang Hospital Beijing, Beijing Municipality, China
  • Beijing Anzhen Hospital,Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
View all 14 locations
View Trial Details
Completed

Limus Eluted From A Durable Versus ERodable Stent Coating

NCT00389220

Conditions
Cardiovascular Diseases, Coronary Disease, Coronary Restenosis, +4 more
Locations
  • Onze Lieve Vrouw Ziekenhuis, Cardiologisch Centrum, Moorselbaan 164 Aalst, Belgium
  • L'Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Service de Coronarographie, 6, Avenue du Noyer Lambert Massy, France
  • Herzzentrum Leipzig, Innere Medizin/Kardiologie, Struimpellstrasse 39 Leipzig, Germany
  • Universitatsklinikum Munchen, Medizinische Klinik Kardiologie, Ziemssenstrasse 1 Munich, Germany
View Trial Details
Completed

ABSORB Clinical Investigation, Cohort B

NCT00856856

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations
  • St. Vincent's Hospital Melbourne, Victoria, Australia
  • Monash Heart Melbourne, Australia
  • Onze-Lieve VrouweZiekenhuis Aalst, Belgium
  • Skejby Sygehus Aarhus, Denmark
View Trial Details
Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels

NCT01977534

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations
  • Lister Hospital Stevenage, Hertfordshire, United Kingdom
  • Basildon Hospital Basildon, United Kingdom
  • Royal Victoria Hospital Belfast, United Kingdom
  • Glan Clwyd District General Hospital Bodelwyddan, United Kingdom
View all 24 locations
View Trial Details
Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

NCT01086228

Conditions
Angina, Angina Pectoris, Arterial Occlusive Diseases, +18 more
Locations
  • Site Reference ID/Investigator# 104727 Aichi, Japan
  • Site Reference ID/Investigator# 113428 Aichi, Japan
  • Site Reference ID/Investigator# 115745 Aichi, Japan
  • Site Reference ID/Investigator# 104424 Chiba, Japan
View all 47 locations
View Trial Details
Completed

ABSORB EXTEND Clinical Investigation

NCT01023789

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Disease, +9 more
Locations
  • Instituto Cardiovascular de Buenos Aires-ICBA Buenos Aires, Argentina
  • Eastern Heart Clinic, The Prince of Wales Hospital Randwick, New South Wales, Australia
  • Wesley Hospital Auchenflower, Queensland, Australia
  • St. Vincent's Hospital Melbourne, Victoria, Australia
View all 56 locations
View Trial Details
Completed

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

NCT01583608

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations
  • Medical Care Center Prof. Mathey, Prof. Schofer GmbH Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Herzzentrum Brandenburg in Bernau Bernau, Germany
  • Klinikum Coburg GmbH Coburg, Germany
  • Elisabeth-Krankenhaus Essen GmbH Essen, Germany
View Trial Details

Related conditions